Outlook Therapeutics, Inc. (OTLK) said on Tuesday that it has appointed Bob Jahr as Chief Executive Officer.
Subsequently, the company's Chief Financial Officer, Lawrence A. Kenyon, who has been serving with the additional role of interim CEO, will continue to work as CFO.
Prior to joining Outlook, Jahr had worked as the Chief Commercial Officer for Sobi North America. Earlier, he had served as General Manager & Vice President Head of International Markets at UCB Pharma SA.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.